SCHEMBL4906048

SCHEMBL4906048

CCN(Sc1ccc(C(F)(F)F)cc1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.45
TSHR P16473 1/20 0.45
CFTR P13569 1/20 0.39
RORC P51449 1/20 0.39
GAA P10253 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KMT2A Q03164 1/20 0.38
KCNJ6 P48051 1/20 0.38
KCNJ3 P48549 1/20 0.38
NPSR1 Q6W5P4 3/20 0.37
HDAC8 Q9BY41 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905552 0.95 ALDH1A1 (0.41) ALDH1A1TSHRCFTRRORCGAA
SCHEMBL4899260 0.91 ALDH1A1 (0.46) ALDH1A1TSHRGAAL3MBTL1KMT2A
SCHEMBL4906088 0.90 ALDH1A1 (0.45) ALDH1A1TSHRCFTRRORCGAA
SCHEMBL4899866 0.89 LMNA (0.40) ALDH1A1L3MBTL1KMT2AKCNJ6KCNJ3
SCHEMBL4904399 0.89 ALDH1A1 (0.46) ALDH1A1TSHRGAAL3MBTL1KMT2A
SCHEMBL4908910 0.89 ALDH1A1 (0.39) ALDH1A1TSHRCFTRRORCGAA
SCHEMBL4905613 0.87 ALDH1A1 (0.48) ALDH1A1TSHRGAAKMT2AHCRTR1
SCHEMBL4894507 0.87 ALDH1A1 (0.48) ALDH1A1TSHRGAAL3MBTL1KMT2A
SCHEMBL4900555 0.86 ALDH1A1 (0.41) ALDH1A1TSHRCFTRRORCGAA
SCHEMBL4906561 0.86 ALDH1A1 (0.44) ALDH1A1TSHRGAAKMT2AHDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885TSHR 412/4885CFTR 2805/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885CFTR 3077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.